Table 2.
Characteristics of HMOs at 1-month postpartum.
| HMO Summary Measures (nmol/mL) | Mean ± SD |
|---|---|
| Diversity* | 5.1 ± 1.9 |
| Sum of HMOs | 16883.9 ± 1813.0 |
| HMO-bound sialic acid | 3431.5 ± 888.4 |
| HMO-bound fucose | 14583.0 ± 2036.6 |
| HMO Concentrations (nmol/mL) | Mean ± SD |
| 2’FL | 6771.4 ± 3175.6 |
| 3FL | 748.2 ± 1151.5 |
| 3’SL | 592.5 ± 658.9 |
| 6’SL | 956.5 ± 315.9 |
| DFLac | 475.6 ± 292.5 |
| DFLNH | 159.0 ± 122.2 |
| DFLNT | 1491.4 ± 815.2 |
| DSLNH | 159.0 ± 122.2 |
| DSLNT | 389.1 ± 179.7 |
| FDSLNH | 114.2 ± 98.1 |
| FLNH | 137.6 ± 112.0 |
| LnNT | 625.0 ± 322.7 |
| LNT | 1130.1 ± 667.2 |
| LNFP I | 1656.7 ± 1056.4 |
| LNFP II | 842.4 ± 387.7 |
| LNFP III | 60.4 ± 29.1 |
| LNH | 92.4 ± 61.4 |
| LSTb | 88.1 ± 54.0 |
| LSTc | 318.4 ± 152.3 |
Baseline (1-month) summary of HMOs among 98 Latina mothers from the Southern California Mother’s Milk Study. Data are reported as mean and standard deviation (SD). *Diversity was estimated using Simpson’s Diversity measure.